Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 6
2003 7
2004 9
2005 10
2006 9
2007 6
2008 2
2009 13
2010 17
2011 5
2012 14
2013 10
2014 7
2015 15
2016 21
2017 20
2018 26
2019 19
2020 20
2021 27
2022 24
2023 25
2024 30
2025 15

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

315 results

Results by year

Filters applied: . Clear all
Page 1
Levels and determinants of exposure to perfluoroalkyl substances in French pregnant women from the SEPAGES cohort.
Jovanovic N, Brantsæter AL, Lyon-Caen S, Duval B, Carras S, Bédard A, Ait-Hadad W, de Lauzon-Guillain B, Siroux V, Bayat S, Steffensen IL, Slama R, Haug LS, Philippat C. Jovanovic N, et al. Among authors: carras s. Environ Int. 2025 May 27;201:109559. doi: 10.1016/j.envint.2025.109559. Online ahead of print. Environ Int. 2025. PMID: 40480099 Free article.
Comparison of Electronic Surveillance With Routine Monitoring for Patients With Lymphoma at High Risk of Relapse: Prospective Randomized Controlled Phase 3 Trial (Sentinel Lymphoma).
Le Dû K, Chauchet A, Sadot-Lebouvier S, Fitoussi O, Fontanet B, Saint-Lezer A, Maloisel F, Rossi C, Carras S, Parcelier A, Balavoine M, Septans AL. Le Dû K, et al. Among authors: carras s. JMIR Cancer. 2025 May 6;11:e65960. doi: 10.2196/65960. JMIR Cancer. 2025. PMID: 40327037 Free PMC article. Clinical Trial.
Atezolizumab, obinutuzumab and venetoclax for the treatment of patients with relapsed/refractory B non-Hodgkin lymphoma: Final analysis of a phase II trial from the LYSA group.
Herbaux C, Bachy E, Bouabdallah R, Guidez S, Casasnovas O, Feugier P, Damaj G, Tilly H, Ysebaert L, Le Gouill S, Morineau N, Gyan E, Gressin R, Houot R, Cheminant M, Morschhauser F, Thieblemont C, Haioun C, Nicolas-Virelizier E, Fornecker LM, Daguindau N, Cartron G. Herbaux C, et al. Among authors: gressin r. Br J Haematol. 2025 Apr 26. doi: 10.1111/bjh.20109. Online ahead of print. Br J Haematol. 2025. PMID: 40285420
Validation of POD24 as a robust early clinical indicator of poor survival in mantle cell lymphoma from 1280 patients on clinical trials, a LYSA study.
Sarkozy C, Chartier L, Ribrag V, Gressin R, Geisler CH, Kluin-Nelemans HC, Thieblemont C, Morschhauser F, Lemonnier F, Safar V, Tessoulin B, Oberic L, Damaj G, Ghesquières H, Bouabdallah K, Casasnovas RO, Houot R, Klapper W, Burroni B, Pott C, Delfau-Larue MH, Macintyre E, Callanan M, Jerkeman M, Unterhalt M, Hoster E, Dreyling M, Le Gouill S, Hermine O, Cheminant M. Sarkozy C, et al. Among authors: gressin r. Blood Cancer J. 2025 Apr 24;15(1):78. doi: 10.1038/s41408-025-01241-9. Blood Cancer J. 2025. PMID: 40274771 Free PMC article.
Targeted therapies overcome the poor prognosis of stereotyped Subset#2 chronic lymphocytic leukemia : a real-world multicentric study.
Bussot L, Poulain S, Nudel Ortmans M, Davi F, Roos-Weil D, Lepretre S, Richard D, Pastoret C, Desmares A, Ferrant E, Huet S, Sujobert P, Delabesse E, Ysebaert L, Lazarian G, Michallet AS, Bidet A, Dilhuydy MS, Delfau-Larue MH, Dupuis J, Clavert A, Drenou B, Maitre E, Troussard X, Cornet E, Le Bris Y, Lok A, Villemagne B, Barbier H, Béné MC, Tomowiak C, Tardy S, Cornillet-Lefebvre P, Quinquenel A, Guièze R, Barbieux S, Plantier I, Hieulle J, Gresta PF, Cornillon J, Dupire S, Laribi K, Feugier P, Algrin C, Lachenal F, Caillet A, Murati A, Inchiappa L, Lechat C, Dartigeas C, Montaut É, Molina L, Carras S. Bussot L, et al. Among authors: carras s. Leukemia. 2025 May;39(5):1247-1251. doi: 10.1038/s41375-025-02555-0. Epub 2025 Apr 1. Leukemia. 2025. PMID: 40169763 Free PMC article. No abstract available.
Erratum to: Bendamustine and rituximab as first-line treatment for symptomatic splenic marginal zone lymphoma: long-term outcome and impact of early unmeasurable minimal residual disease attainment from the BRISMA/IELSG36 phase II study.
Iannitto E, Ferrero S, Bommier C, Drandi D, Ferrante M, Bouabdallah K, Carras S, Gini G, Camus V, Mancuso S, Marcheselli L, Ferrari A, Merli M, Tessoulin B, Stelitano C, Beldjord K, Roti G, Jardin F, Castagnari B, Palombi F, Baseggio L, Traverse-Glehen A, Tripodo C, Liberati AM, Parolini M, Usai S, Patti C, Federico M, Musso M, Ladetto M, Zucca E, Thieblemont C. Iannitto E, et al. Among authors: carras s. Haematologica. 2025 Apr 1;110(4):1048-1049. doi: 10.3324/haematol.2024.287031. Epub 2025 Apr 1. Haematologica. 2025. PMID: 40165734 Free PMC article. No abstract available.
A low lymphocyte-to-monocyte ratio is independently associated with early relapse (POD24) in high tumour burden follicular lymphoma: A RELEVANCE subanalysis.
Mozas P, Ould Ammar R, Chartier L, Nastoupil L, Bachy E, Bezsera SM, Barnes J, Bijou F, Goy A, Zerazhi H, Cartron G, Ojeda-Uribe M, Choquet S, Joly B, Cheminant M, Martín García-Sancho A, Eradat H, Gressin R, Abrisqueta P, Parcelier A, Rodríguez Salazar MJ, Bonnet C, Johnson NA, López-Guillermo A, Morschhauser F. Mozas P, et al. Among authors: gressin r. Br J Haematol. 2025 May;206(5):1380-1389. doi: 10.1111/bjh.20038. Epub 2025 Mar 3. Br J Haematol. 2025. PMID: 40031898
Outcomes of patients with relapsed or refractory primary mediastinal B-cell lymphoma treated with anti-CD19 CAR-T cells: CARTHYM, a study from the French national DESCAR-T registry.
Galtier J, Mesguich C, Sesques P, Dupont V, Bachy E, Di Blasi R, Thieblemont C, Gastinne T, Cartron G, Brisou G, Gros FX, Decroocq J, Morschhauser F, Rubio MT, Drieu La Rochelle L, Le Bras F, Carras S, Chauchet A, Bay JO, Joris M, Loschi M, Tanguy-Schmidt A, Marquet A, Camus V, Le Gouill S, Houot R, Bouabdallah K. Galtier J, et al. Among authors: carras s. Hemasphere. 2025 Feb 18;9(2):e70091. doi: 10.1002/hem3.70091. eCollection 2025 Feb. Hemasphere. 2025. PMID: 39968186 Free PMC article.
315 results